Pharmicell (005690) — Capital Reinvestment Ratio
Pharmicell (005690) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩8.78 Billion) in capital expenditures (₩622.48 Million). Check Pharmicell (005690) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pharmicell Capital Reinvestment Ratio (2016–2024)
This chart tracks Pharmicell's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see 005690 cash flow metrics.
Annual Capital Reinvestment Ratio for Pharmicell (2016–2024)
Year-by-year Capital Reinvestment Ratio for Pharmicell from 2016 to 2024. See free cash flow generation of Pharmicell to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.24x | ₩3.50 Billion | ₩4.34 Billion | ▲ +143.3% |
| 2023 | 0.51x | ₩11.81 Billion | ₩6.02 Billion | ▼ -78.7% |
| 2022 | 2.40x | ₩7.91 Billion | ₩18.96 Billion | ▲ +2795.5% |
| 2020 | 0.08x | ₩8.98 Billion | ₩742.73 Million | ▼ -94.0% |
| 2018 | 1.37x | ₩3.40 Billion | ₩4.68 Billion | ▼ -64.7% |
| 2016 | 3.89x | ₩988.97 Million | ₩3.85 Billion | — |